this post was submitted on 17 Jul 2023
8 points (100.0% liked)

Science

18 readers
2 users here now

This magazine is dedicated to discussions on scientific discoveries, research, and theories across various fields, including physics, chemistry, biology, astronomy, and more. Whether you are a scientist, a science enthusiast, or simply curious about the world around us, this is the place for you. Here you can share your knowledge, ask questions, and engage in discussions on a wide range of scientific topics. From the latest breakthroughs to historical discoveries and ongoing research, this category covers a wide range of topics related to science.

founded 2 years ago
 

The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.

you are viewing a single comment's thread
view the rest of the comments
[–] OptimisticPrime@lemmy.fmhy.ml 2 points 1 year ago* (last edited 1 year ago)

Sure, but treatments of something that complex has to start somewhere. It seems to go in the right direction and upcoming treatments may build on that. I am not sure that anyone could have expected after many failures to just find the magical cure that completely cures Alzheimers.